Figure 1.
Decision tree for cost-effectiveness analysis of different screening strategies among all simulated live births in China.
Table 1.
Parameter values and plausible ranges for probability variables used in baseline and sensitivity analysis.
Table 2.
Estimation of cases detected and cases intervened by different screening strategies.
Table 3.
Costs, health effects, and cost-effectiveness of different screening strategies.
Figure 2.
The cost in per Disability-Adjusted Life Years (DALYs) of four screening strategies compared with no screening.
Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Select.OAE+AABR = targeted strategy using OAE plus AABR; Select.OAE = targeted strategy using OAE; Reference = 3 times of GDP per capita (19,700 international dollars).
Figure 3.
Sensitivity analysis of willingness-to-pay.
Figure 4.
The impact of the benefit ratio on ACER of different screening strategies based on the results of sensitivity analysis.
Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Select.OAE+AABR = targeted strategy using OAE plus AABR; Select.OAE = targeted strategy using OAE; ACER = Average Cost-Effectiveness Ratio.
Figure 5.
The impact of the benefit ratio on ICER of shifting strategies based on the results of sensitivity analysis.
Uni.OAE+AABR = universal strategy using OAE plus AABR; Uni.OAE = universal strategy using OAE; Select.OAE+AABR = targeted strategy using OAE plus AABR; Select.OAE = targeted strategy using OAE; ICER = Incremental Cost-Effectiveness Ratio.